Stay updated on Lintuzumab-Ac225 in Older AML Patients Clinical Trial

Sign up to get notified when there's something new on the Lintuzumab-Ac225 in Older AML Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lintuzumab-Ac225 in Older AML Patients Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.
    Difference
    0.2%
    Check dated 2025-09-14T18:45:22.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, and a 'Back to Top' feature has been added.
    Difference
    0.2%
    Check dated 2025-09-07T13:11:23.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, along with a comprehensive list of drug information, particularly various chemical compounds and medications. However, many specific medical topics and related resources have been removed.
    Difference
    5%
    Check dated 2025-08-31T05:46:25.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The web page now includes information about a Phase I trial of alpha-particle immunotherapy involving 225Ac-lintuzumab and low-dose cytarabine for patients aged 60 or older with untreated acute myeloid leukemia.
    Difference
    1%
    Check dated 2025-08-24T03:11:42.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The page has removed a significant clinical trial description related to a specific treatment for acute myeloid leukemia, which may impact the understanding of available therapies for patients. Additionally, the version number has been updated from v2.16.11 to v2.16.12.
    Difference
    1%
    Check dated 2025-08-16T22:19:39.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.11, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.9%
    Check dated 2025-08-09T18:46:18.000Z thumbnail image

Stay in the know with updates to Lintuzumab-Ac225 in Older AML Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lintuzumab-Ac225 in Older AML Patients Clinical Trial page.